International Symposium on Biomedical Engineering and Healthcare Technologies

Attendees, exhibitors & solutions

Who this event is for

Industry trends

Key trends shaping this market and its wider industry.

Arrival airports

Choose from the following airports, with convenient access to the event and venue.

Hotel tiers

A range of accommodation options near the venue and across key areas.

Local transport

Get around the city with these convenient transport options.

Frequently asked

Glossary

1

Biomedical engineering

The application of engineering principles to healthcare, covering medical devices, diagnostic systems, biomaterials, imaging and clinical software. At this symposium the term spans bench research through regulated clinical deployment.

2

Biomaterials

Natural or synthetic materials designed to interact with biological systems for implants, scaffolds, coatings or drug-delivery components. Exhibitors are expected to show biocompatibility data and manufacturing routes.

3

Tissue engineering

Combining cells, scaffolds and biochemical signals to restore or replace tissue function. Conference content typically addresses scaffold design, bioreactors, sterilization and translation to clinical trials.

4

SaMD (Software as a Medical Device)

Software intended for a medical purpose that performs its function without being part of a hardware medical device. Regulatory pathways depend on risk classification and clinical evidence.

5

ISO 13485

The international quality management system standard for medical device organizations. Suppliers often use it as a baseline for design control, traceability and post-market surveillance.

6

Clinical validation

Evidence that a device or diagnostic performs as intended in the target patient population. Validation packages usually combine analytical performance, usability and clinical outcome data.

7

Point-of-care testing (POCT)

Diagnostic testing performed near the patient rather than in a central laboratory. Relevant product families include rapid immunoassays, molecular cartridges and connected readers.

8

Wearable sensor

A body-worn device that continuously or intermittently captures physiological data such as heart rhythm, oxygen saturation, movement or glucose. Connectivity, battery life and data security are common evaluation criteria.

9

Diagnostic imaging

Technologies such as ultrasound, MRI, CT, X-ray and optical imaging used to visualize anatomy or function. Symposium content may cover image-guided therapy, AI reconstruction and workflow integration.

10

Neuroengineering

Engineering approaches to the nervous system, including neuromodulation, neural interfaces and neuroprosthetics. Sessions often examine electrode materials, signal processing and clinical trial design.

11

Health technology assessment (HTA)

A structured evaluation of clinical effectiveness, cost and organizational impact used by payers and hospitals. Exhibitors may need HTA-style evidence to support adoption in Southeast Asian markets.

12

Design control

The regulated process linking user needs to design inputs, outputs, verification, validation and design transfer. It is a core expectation for medical device quality systems.

13

Biocompatibility

The ability of a material or device to perform its intended function without causing unacceptable local or systemic effects. Testing typically follows ISO 10993 series methods.

14

Regulatory affairs

The function that prepares and maintains market-access submissions and compliance documentation for medical devices, diagnostics and SaMD. In Malaysia this involves the Medical Device Authority (MDA) framework.

15

Interoperability (HL7/FHIR)

The ability of clinical systems to exchange and use data using standards such as HL7 v2, CDA and FHIR. Connected devices and SaMD products are increasingly evaluated on their integration profile.